According to findings from the tests conducted at Spallanzani Hospital in Rome, the vaccine generated antibodies in mice that work on human cells.
These antibodies were observed to prevent the virus from infecting the cells.
Takis Biotech is the company developing the coronavirus vaccine candidate.
An Italian news agency, ANSA, quoted Takis Biotech CEO Luigi Aurisicchio as saying: “This is the most advanced stage of testing of a candidate vaccine created in Italy. Human tests are expected after this summer.”
Takis was allegedly exploring options with US-based LineaRx. However, the company requires the Italian government’s support and alliances with international bodies to further develop the vaccine, added Aurisicchio.
Aurisicchio also noted: “This is not a competition. If we join our forces and skills together, we can all win against coronavirus.”
Source: Websites
